Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Blood|March 25, 2006
Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology GroupJoanne M Hilden, Patricia A Dinndorf, Sharon O Meerbaum, et al.
Pediatric Blood & Cancer|July 1, 2014
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology GroupTerzah M Horton, John P Perentesis, Alan S Gamis, et al.
Nature Communications|November 21, 2013
Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia ALily M Du, Paquita Nurden, Alan T Nurden, et al.
Pediatric Blood & Cancer|June 18, 2011
A phase II study of amifostine in children with myelodysplastic syndrome: a report from the Children's Oncology Group study (AAML0121)Prasad Mathew, Robert Gerbing, Todd A Alonzo, et al.
Cancer|March 7, 2012
Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology GroupApril D Sorrell, Todd A Alonzo, Joanne M Hilden, et al.
Cancer|July 19, 2011
AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology GroupTodd M Cooper, Janet Franklin, Robert B Gerbing, et al.
Blood|March 14, 2007
Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 geneCary Hsu, Stephanie A Jones, Cyrille J Cohen, et al.
Pediatric Blood & Cancer|April 6, 2011
Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology GroupMartin A Champagne, Cecilia H Fu, Myron Chang, et al.
Blood|August 19, 2011
Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971Alan S Gamis, Todd A Alonzo, Robert B Gerbing, et al.
Blood Advances|April 20, 2026
Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell DiseaseChattip Prueksapraopong, Augustine Fernandes, Beatriz Campo Fernandez, et al.
Pageof 15